Mergers & AcquisitionsBy The Online Investor Staff, updated Fri., Oct. 22, 6:14 PM
|This Slide: #4 of 100|
Slide #4. 23andMe Holding Co. — Lemonaid Health, Inc.
23andMe Holding Co. (NASDAQ:ME)
Lemonaid Health, Inc.
23andMe Holding Co. (Nasdaq: ME) ("23andMe"), a leading consumer genetics and research company, today announced the signing of a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online. Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition is expected to close by the end of 2021.
23andMe Holding is a newly blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Open the ME Page at The Online Investor »
Free ME Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Buy (2.64 out of 4)
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite